Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Alzheimer disease rat model offers insights into biomarker identification
November 18th, 2005
Samaritan Pharmaceuticals Inc. (LIV) announced that its "Alzheimer Rat Model," a tool which enables researchers to create an Alzheimer disease-like profile in rats and test new Alzheimer drugs, closely reproduces the phenotype of Alzheimer. A manuscript describing the model was published in the Journal Pharmacology (2006, vol. 76, pages 19-33). Dr. Janet Greeson, CEO of Samaritan stated, "What we have found to be so important about this animal model is that there are concomitant changes in neurohistopathology, and memory loss, coupled with changes in spinal fluid proteins (a method used to diagnose Alzheimer disease in humans.) We believe this...
Source: Drug Week (2005-11-18)
|
